Cochrane Nigeria’s Post

Can Magnesium Sulphate Protect Babies Born Preterm? Research reveals that magnesium sulphate, when administered to women at risk of preterm birth, can reduce the occurrence of cerebral palsy and the combined outcome of death or cerebral palsy in children up to two years old. This is a significant development in neonatal care, with studies showing that magnesium sulphate may protect brain health for infants born before 34 weeks of pregnancy. Key findings: Magnesium sulphate significantly reduces the risk of cerebral palsy or death in children up to two years of age when given to women likely to deliver preterm. There is limited evidence to suggest any significant impact of magnesium sulphate on outcomes for children at early school age. Research will continue to explore its long-term effects and determine optimal delivery methods for diverse groups. Read more: https://lnkd.in/dXtkEYip Authors: Emily S Shepherd, Shona Goldsmith, Lex W Doyle, Philippa Middleton, Stéphane Marret, Dwight J Rouse, Peter Pryde, Hanne T Wolf, Caroline A Crowther #pretermbirth #maternalhealth #neonatalcare #MagnesiumSulphate #cerebralpalsy #healthcareresearch

  • text

To view or add a comment, sign in

Explore topics